Long-term tolerability of inhaled human insulin (Exubera®) in patients with poorly controlled type 2 diabetes (vol 61, pg 1614, 2007)

被引：0
|
作者：
Barnett, A. H.
Lange, P.
Dreyer, M.
Serdarevic-Pehar, M.
机构：
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2008年 / 62卷 / 01期
关键词：
D O I：
10.1111/j.1742-1241.2007.01664.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：171 / 171
页数：1
相关论文
共 50 条
  • [21] Will availability of inhaled human insulin (Exubera®) improve management of type 2 diabetes?: The design of the Real World trial
    Freemantle, Nick
    Strack, Thomas R.
    TRIALS, 2006, 7 (1)
  • [22] Sustained long-term efficacy and safety of inhaled human insulin (Exubera*) following at least 8 years of continuous therapy
    Burge, M. R.
    Reis, J. M.
    Krasner, A. S.
    Schwartz, P. F.
    Teeter, J. G.
    DIABETOLOGIA, 2007, 50 : S400 - S400
  • [23] Long-term efficacy and tolerability of acarbose treatment in patients with type 2 diabetes mellitus
    Segal, P
    Eliahou, HE
    Petzinna, D
    Neuser, D
    Brückner, A
    Spengler, M
    CLINICAL DRUG INVESTIGATION, 2005, 25 (09) : 589 - 595
  • [24] Long-Term Efficacy and Tolerability of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus
    Pesach Segal
    Haskel E. Eliahou
    Dieter Petzinna
    Dieter Neuser
    Andreas Brückner
    Manfred Spengler
    Clinical Drug Investigation, 2005, 25 : 589 - 595
  • [25] Long-term improvement of metabolic control by acarbose in type 2 diabetes patients poorly controlled with maximum sulfonylurea therapy
    Bachmann, W
    Petzinna, D
    Raptis, SA
    Wascher, T
    Westermeier, T
    CLINICAL DRUG INVESTIGATION, 2003, 23 (10) : 679 - 686
  • [26] Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy
    Werner Bachmann
    Dieter Petzinna
    Sotirios A. Raptis
    Thomas Wascher
    Torsten Westermeier
    Clinical Drug Investigation, 2003, 23 : 679 - 686
  • [27] Randomized study to characterize glycemic control and short-term pulmonary function in patients with type 1 diabetes receiving inhaled human insulin (Exubera)
    Norwood, Paul
    Dumas, Richard
    Cefalu, William
    Yale, Jean-Francois
    England, Richard
    Riese, Richard
    Teeter, John
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (06): : 2211 - 2214
  • [28] An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with meformin as adjunctive therapy in patients with type 2 diabetes poorly controlled on a sulfonylurea - Response to Mikhail and Cope
    Barnett, Anthony H.
    Dreyer, Manfred
    Lange, Peter
    Serdarevic-Pehar, Marjana
    DIABETES CARE, 2006, 29 (10) : 2333 - 2334
  • [29] Patient satisfaction and glycemic control after 1 year with inhaled insulin (exubera) patients with type 1 or type 2 diabetes
    Rosenstock, J
    Cappelleri, JC
    Bolinder, B
    Gerber, RA
    DIABETES CARE, 2004, 27 (06) : 1318 - 1323
  • [30] Hepatic Insulin Clearance Is Increased in the Patients with Poorly Controlled Type 2 Diabetes
    Okura, Tsuyoshi
    Anno, Mari
    Ito, Yuichi, Sr.
    DIABETES, 2018, 67
12345